Artículos por temáticas

Genistein ameliorates learning and memory deficits in amyloid β(1-40) rat model of Alzheimer's disease

Bagheri M, Joghataei MT, Mohseni S, Roghani M.

Neurobiol Learn Mem. 2011 Mar;95(3):270-6. doi: 10.1016/j.nlm.2010.12.001. Epub 2010 Dec 7.

A man with severe Alzheimer's disease stops wandering during a picture colouring activity

Lancioni GE, Perilli V, Singh NN, O'Reilly MF, Cassano G.

Dev Neurorehabil. 2011;14(4):242-6. doi: 10.3109/17518423.2011.575439.

Carotid plaque in Alzheimer caregivers and the role of sympathoadrenal arousal

Roepke SK, Chattillion EA, von Känel R, Allison M, Ziegler MG, Dimsdale JE, Mills PJ, Patterson TL, Ancoli-Israel S, Calleran S, Harmell AL, Grant I.

Psychosom Med. 2011 Feb-Mar;73(2):206-13. doi: 10.1097/PSY.0b013e3182081004. Epub 2011 Jan 7.

Caring for older people at home

Roe B.

J Adv Nurs. 2011 Nov;67(11):2293. doi: 10.1111/j.1365-2648.2011.05831.x.

Effects of body weight on tolerability of rivastigmine transdermal patch: a post-hoc analysis of a double-blind trial in patients with Alzheimer disease

Lee JH, Sevigny J.

Alzheimer Dis Assoc Disord. 2011 Jan-Mar;25(1):58-62. doi: 10.1097/WAD.0b013e3181f32829.

Information and communication technology systems to improve quality of life and safety of Alzheimer's disease patients: a multicenter international survey

Pilotto A, D'Onofrio G, Benelli E, Zanesco A, Cabello A, Margelí MC, Wanche-Politis S, Seferis K, Sancarlo D, Kilias D.

J Alzheimers Dis. 2011;23(1):131-41. doi: 10.3233/JAD-2010-101164.

Treatment with cholinesterase inhibitors and memantine of patients in the Alzheimer's Disease Neuroimaging Initiative

Schneider LS, Insel PS, Weiner MW; Alzheimer's Disease Neuroimaging Initiative.

Arch Neurol. 2011 Jan;68(1):58-66. doi: 10.1001/archneurol.2010.343.

[Alzheimer's disease and care needs: what do nurses know?]

Poltroniere S, Cecchetto FH, de Souza EN.

Rev Gaucha Enferm. 2011 Jun;32(2):270-8. doi: 10.1590/s1983-14472011000200009.

Reliability and validity of the Norwegian version of the Brief Agitation Rating Scale (BARS) in dementia

Sommer OH, Engedal K.

Aging Ment Health. 2011 Mar;15(2):252-8. doi: 10.1080/13607863.2010.519318. Epub 2010 Dec 6.

MR spectroscopy for assessment of memantine treatment in mild to moderate Alzheimer dementia

Ashford JW, Adamson M, Beale T, La D, Hernandez B, Noda A, Rosen A, O'Hara R, Fairchild JK, Spielman D, Yesavage JA.

J Alzheimers Dis. 2011;26 Suppl 3(0 3):331-6. doi: 10.3233/JAD-2011-0021.

Consequences of antipsychotic medications for the dementia patient

Devanand DP, Schultz SK.

Am J Psychiatry. 2011 Aug;168(8):767-9. doi: 10.1176/appi.ajp.2011.11040629.

PF-04494700, an oral inhibitor of receptor for advanced glycation end products (RAGE), in Alzheimer disease

Sabbagh MN, Agro A, Bell J, Aisen PS, Schweizer E, Galasko D.

Alzheimer Dis Assoc Disord. 2011 Jul-Sep;25(3):206-12. doi: 10.1097/WAD.0b013e318204b550.

[Special issues regarding the diagnosis and treatment in everyday practice]

Fujimoto N, Okumura N.

Nihon Rinsho. 2011 Dec;69 Suppl 10 Pt 2:257-63.

BACE inhibitors as potential drugs for the treatment of Alzheimer's disease: focus on bioactivity

Evin G, Lessene G, Wilkins S.

Recent Pat CNS Drug Discov. 2011 May 1;6(2):91-106. doi: 10.2174/157488911795933938.

Changes in nursing burden following memantine for agitation and aggression in long-term care residents with moderate to severe Alzheimer's disease: an open-label pilot study

Herrmann N, Cappell J, Eryavec GM, Lanctôt KL.

CNS Drugs. 2011 May;25(5):425-33. doi: 10.2165/11588160-000000000-00000.